These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23625968)

  • 1. Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2.
    Arslan Z; Wurm R; Brener O; Ellinger P; Nagel-Steger L; Oesterhelt F; Schmitt L; Willbold D; Wagner R; Gohlke H; Smits SH; Pul U
    Nucleic Acids Res; 2013 Jul; 41(12):6347-59. PubMed ID: 23625968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA exit ramps are revealed in the binding landscapes obtained from simulations in helical coordinates.
    Echeverria I; Papoian GA
    PLoS Comput Biol; 2015 Feb; 11(2):e1003980. PubMed ID: 25675216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
    Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
    Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity.
    Nuñez JK; Lee AS; Engelman A; Doudna JA
    Nature; 2015 Mar; 519(7542):193-8. PubMed ID: 25707795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation.
    Wei Y; Terns RM; Terns MP
    Genes Dev; 2015 Feb; 29(4):356-61. PubMed ID: 25691466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screens in human cells using the CRISPR-Cas9 system.
    Wang T; Wei JJ; Sabatini DM; Lander ES
    Science; 2014 Jan; 343(6166):80-4. PubMed ID: 24336569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity.
    Nuñez JK; Kranzusch PJ; Noeske J; Wright AV; Davies CW; Doudna JA
    Nat Struct Mol Biol; 2014 Jun; 21(6):528-34. PubMed ID: 24793649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale CRISPR-Cas9 knockout screening in human cells.
    Shalem O; Sanjana NE; Hartenian E; Shi X; Scott DA; Mikkelson T; Heckl D; Ebert BL; Root DE; Doench JG; Zhang F
    Science; 2014 Jan; 343(6166):84-87. PubMed ID: 24336571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
    Goldberg GW; Jiang W; Bikard D; Marraffini LA
    Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
    van der Oost J; Westra ER; Jackson RN; Wiedenheft B
    Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array.
    Yosef I; Shitrit D; Goren MG; Burstein D; Pupko T; Qimron U
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14396-401. PubMed ID: 23940313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.
    Gilbert LA; Larson MH; Morsut L; Liu Z; Brar GA; Torres SE; Stern-Ginossar N; Brandman O; Whitehead EH; Doudna JA; Lim WA; Weissman JS; Qi LS
    Cell; 2013 Jul; 154(2):442-51. PubMed ID: 23849981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal Structure of Streptococcus pyogenes Cas1 and Its Interaction with Csn2 in the Type II CRISPR-Cas System.
    Ka D; Lee H; Jung YD; Kim K; Seok C; Suh N; Bae E
    Structure; 2016 Jan; 24(1):70-79. PubMed ID: 26671707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and evolution of type II CRISPR-Cas systems.
    Chylinski K; Makarova KS; Charpentier E; Koonin EV
    Nucleic Acids Res; 2014 Jun; 42(10):6091-105. PubMed ID: 24728998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of foreign DNA recognition by a CRISPR RNA-guided surveillance complex from Pseudomonas aeruginosa.
    Rollins MF; Schuman JT; Paulus K; Bukhari HS; Wiedenheft B
    Nucleic Acids Res; 2015 Feb; 43(4):2216-22. PubMed ID: 25662606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 protein.
    Hooton SP; Connerton IF
    Front Microbiol; 2014; 5():744. PubMed ID: 25601859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli.
    Jackson RN; Golden SM; van Erp PB; Carter J; Westra ER; Brouns SJ; van der Oost J; Terwilliger TC; Read RJ; Wiedenheft B
    Science; 2014 Sep; 345(6203):1473-9. PubMed ID: 25103409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer.
    Richter C; Dy RL; McKenzie RE; Watson BN; Taylor C; Chang JT; McNeil MB; Staals RH; Fineran PC
    Nucleic Acids Res; 2014 Jul; 42(13):8516-26. PubMed ID: 24990370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.